Skip to main content

Table 1 Clinical characteristics at admission and at weaning trial in patients that succeeded and failed CPAP weaning

From: Predictors of weaning from helmet CPAP in patients with COVID-19 pneumonia

Characteristics

Weaning success (n = 61)

Weaning failure (n = 13)

p valuea

Age, years

62 (12)

74 (8)

0.001

Males, n (%)

43 (70)

8 (61)

0.526

Hypertension, n (%)

30 (49)

7 (54)

0.760

Diabetes mellitus, n (%)

13 (21)

3 (23)

0.999

Ischemic heart disease, n (%)

6 (10)

4 (31)

0.067

Obesity, n (%)

26 (43)

6 (46)

0.816

Respiratory disease, n (%)

10 (16)

0 (0)

0.116

CPAP days at weaning trial

4 (2–6)

4 (2.5–5)

0.854

In-Hospital treatments

Antibiotics, n (%)

50 (82.0%)

9 (69.2%)

0.446

LMWH prophylactic, n (%)

39 (63.9%)

8 (61.5%)

0.999

LMWH therapeutic, n (%)

30 (49.2%)

9 (69.2%)

0.189

Systemic corticosteroids, n (%)

46 (75.4%)

9 (69.2%)

0.729

Clinical status at admission

Lymphocytes, × 106/L

900 (600–1400)

800 (700–1000)

0.931

D-Dimer, µg/L FEU

888 (572–2101)

1056 (544–1632)

0.922

CRP, mg/L

85 (42–127)

110 (85–215)

0.060

Creatinine, mg/dL

0.8 (0.7–1.0)

0.9 (0.8–1.6)

0.091

BUN, mg/dL

38 (28–53)

52 (34–70)

0.093

Glasgow coma scale

15 (15–15)

15 (14.5–15)

0.067

SOFA

2 (2–3)

3 (2–4.5)

0.204

Respiratory rate, bpm

24 (22–29)

26 (24–33)

0.275

PaO2/FiO2, mmHg

194 (122–273)

140 (86.7–281.0)

0.604

A-a O2 gradient, mmHg

204 (69–325)

242 (66–336)

0.960

pH

7.48 (0.05)

7.49 (0.05)

0.389

PaCO2, mmHg

36 (7)

35 (9)

0.598

ROX index

7.6 (4.8–14.5)

8.1 (4.3–16.3)

0.889

Clinical status the day of weaning trial

D-Dimer, µg/L FEU

899 (545–1425)

1244 (845–1375)

0.183

CRP, mg/L

36 (9–59)

70 (18–115)

0.085

SOFA

2 (1.5 – 3)

3 (3–4)

0.003

GCS

15 (15–15)

15 (15–15)

0.423

A-a O2 gradient, mmHg

208 (151–269)

245 (206–445)

0.010

PaO2/FiO2, mmHg

243 (98)

171 (56)

0.014

Respiratory rate, bpm

20 (18–22)

24 (22–27)

< 0.001

pH

7.45 (7.42–7.47)

7.44 (7.42–7.48)

0.638

PaCO2, mmHg

42 (6)

41 (6)

0.653

ROX index

9 (8–11)

7.4 (4.1–8.5)

0.002

mROX index, mmHg/bpm

11.9 (8.5–14.3)

6.6 (5.6–8.8)

< 0.001

  1. Parametric and nonparametric quantitative variables are described with means (standard deviations, SD) and medians (interquartile ranges, IQR), respectively. Chi-squared or Fisher exact test were used to compare qualitative variables, whereas Student t test or Mann–Whitney were used to compare quantitative variables with normal or non-normal distribution, respectively, in patients that failed or succeeded the weaning trial
  2. A-a O2 gradient = alveolar-arterial oxygen gradient; BUN = blood urea nitrogen; CPAP = continuous positive airway pressure; CRP = C reactive protein (upper limit of normal 10 mg/L); FEU = fibrinogen equivalent units; GCS = Glasgow Coma Scale; LMWH = low molecular weight heparin; PaO2 = arterial partial pressure of oxygen; PaCO2 = arterial partial pressure of carbon dioxide; ROX index = SpO2/FiO2/respiratory rate; mROX index = PaO2/FiO2/respiratory rate; SOFA = Sequential Organ Failure Assessment